相关实验视频
Updated: Jul 25, 2025

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
671
研究糖尿病及其并发症的实验模型:局限性和新机遇
Beatriz Martín-Carro1,2, Javier Donate-Correa2,3, Sara Fernández-Villabrille1,2
1Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
International journal of molecular sciences
|June 28, 2023
概括
本综述检查了糖尿病 (DM) 的临床前老鼠模型,突出了它们在理解疾病机制方面的有用性和局限性. 它强调选择适合研究目标的模型,并开发长期研究,以更好地反映人类糖尿病并发症.
科学领域:
- 临床前研究 临床前研究
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 临床前生物医学模型对于推进疾病知识至关重要,特别是对于糖尿病 (DM),其中潜在的机制和治疗仍然难以捉摸.
- 目前的研究往往侧重于早期的DM,需要更好地代表人类糖尿病的慢性,多因素性质的模型.
研究的目的:
- 审查糖尿病常用老鼠模型的特点,优点和局限性.
- 根据研究目标,指导研究人员选择最合适的DM模型.
- 强调需要长期研究,更准确地模仿人类糖尿病的进展和并发症.
主要方法:
- 对1型糖尿病 (易患生物育种糖尿病,LEW.1AR1-iddm) 的自发性大鼠模型的审查.
- 对2型糖尿病的自发性大鼠模型的审查 (糖糖尿病脂肪,Goto-kakizaki).
- 综述诱导的DM模型 (手术,饮食,药物 - 素,链毒素),包括一种新的链毒素诱导模型与胰岛素治疗模仿慢性DM.
主要成果:
- 对于1型和2型糖尿病都有各种不同的老鼠模型,每个都有特定的特征.
- 现有的模型存在局限性,包括不统一的协议和对人类糖尿病长期并发症的不完全表示.
- 一个最近开发的链毒素诱导的模型与慢性胰岛素的管理显示了研究DM的慢性阶段的希望.
结论:
- 选择合适的临床前糖尿病模型至关重要,并且取决于具体的研究目标.
- 显著需要开发和利用长期临床前研究,以更好地回顾人类糖尿病的复杂性.
- 持续完善现有模型和开发新的模型对于推进糖尿病研究至关重要.
相关概念视频
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319

